Orthopedic Devices: Accelerated Rate of Change and Regulatory Uncertainty--Performance, Capabilities, Goals and Strategies of Leading Suppliers
This report provides a worldwide strategic overview of the orthopedics market, including forecasts for major geographic regions, market segments and product categories.
In addition, the report presents a concise review of the major U.S. and international trends with potentially significant impact on the orthopedics market during the next five years, including industry consolidation, market globalization, environmental regulations, etc.
The analysis of major market segments, including reconstructive devices, fracture fixation products, arthroscopy, soft tissue repair, spinal implants and instrumentation, bone growth stimulators, power instruments, casting materials, operating room ancillary products and others is provided, as well as a review of the major geographic regions, including U.S., Europe, Japan/Pacific and others.
The company profiles include:
In addition, the report presents a concise review of the major U.S. and international trends with potentially significant impact on the orthopedics market during the next five years, including industry consolidation, market globalization, environmental regulations, etc.
The analysis of major market segments, including reconstructive devices, fracture fixation products, arthroscopy, soft tissue repair, spinal implants and instrumentation, bone growth stimulators, power instruments, casting materials, operating room ancillary products and others is provided, as well as a review of the major geographic regions, including U.S., Europe, Japan/Pacific and others.
The company profiles include:
- Business, new product development and marketing strategies.
- Major strengths and weaknesses.
- The U.S. and international sales force size.
- Distribution approaches.
- Major promotional tactics.
- Internally developed and acquired technologies.
- Technical expertise in biotechnology, engineering and other pertinent fields.
1. MARKET OVERVIEW
a. U.S.A
1. BUSINESS ENVIRONMENT
a. Health Care Expenditures
b. Cost Consciousness
c. Industry Consolidation
d. Managed Care
e. Hospitals
f. Admissions
g. Length of Stay
h. Industry Diversification
i. Physician Demographics
j. Population Aging
b. Other Countries
2. MARKET SIZE AND GROWTH
a. Major Market Segments
b. Major Geographic Regions
3. EMERGING TECHNOLOGIES
a. Overview
b. Resorbables
c. Bone Substitutes
d. Osteoinductive Agents/Bone Graft Factors
e. Soft Tissue Repair And Replacement
f. Viscoelastics
g. Osteoporosis Therapies
4. LEADING ORTHOPEDICS COMPANIES STRATEGIC DIRECTIONS
Business, new product development and marketing strategies
Anticipated acquisitions, joint ventures and marketing strategies
Major strengths and weaknesses
5. LEADING ORTHOPEDICS COMPANIES MARKETING TACTICS
The U.S. and international sales force size
Distribution approaches
Major promotional tactics
6. LEADING ORTHOPEDICS COMPANIES TECHNOLOGICAL
Know-How
Internally developed and acquired technologies
Technical expertise in biotechnology, engineering and other pertinent fields
a. U.S.A
1. BUSINESS ENVIRONMENT
a. Health Care Expenditures
b. Cost Consciousness
c. Industry Consolidation
d. Managed Care
e. Hospitals
f. Admissions
g. Length of Stay
h. Industry Diversification
i. Physician Demographics
j. Population Aging
b. Other Countries
2. MARKET SIZE AND GROWTH
a. Major Market Segments
b. Major Geographic Regions
3. EMERGING TECHNOLOGIES
a. Overview
b. Resorbables
c. Bone Substitutes
d. Osteoinductive Agents/Bone Graft Factors
e. Soft Tissue Repair And Replacement
f. Viscoelastics
g. Osteoporosis Therapies
4. LEADING ORTHOPEDICS COMPANIES STRATEGIC DIRECTIONS
Business, new product development and marketing strategies
Anticipated acquisitions, joint ventures and marketing strategies
Major strengths and weaknesses
5. LEADING ORTHOPEDICS COMPANIES MARKETING TACTICS
The U.S. and international sales force size
Distribution approaches
Major promotional tactics
6. LEADING ORTHOPEDICS COMPANIES TECHNOLOGICAL
Know-How
Internally developed and acquired technologies
Technical expertise in biotechnology, engineering and other pertinent fields
More Publications
Siemens 2019: US, Europe, Japan--Market Shares by Test and Country, Competitive Position by Product
US$ 3,500.00
July 2019
179 pages
Cyclosporin Test Volume and Sales Forecasts 2021: US, Europe, Japan-Hospitals, Commercial Labs, POC Locations
US$ 750.00
September 2017
-
2016-2020 Spain Genetic Diseases, Cancer, Forensic and Paternity Molecular Diagnostic Testing Markets: Country Forecasts, Emerging Technologies, Competitive Landscape
US$ 1,480.00
March 2016
407 pages
2016-2020 Emerging Clinical Chemistry and Immunodiagnostic Tests, and Strategic Profiles of Leading Reagent and Instrument Suppliers
US$ 3,080.00
March 2016
320 pages